*Prices reflect U.S. average retail price

Lacosamide (INN, formerly known as erlosamide, harkeroside, SPM 927, or ADD 234037), is a medication for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. It is marketed under the trade name Vimpat.... Wikipedia

Manufacturer's Website: Vimpat                                                                                                                            Average retail cost: $1,277/month